Tremilad 150 Driada Medical EU

Manufacturer: Driada Medical
Active Substance: Trenbolone acetate: 50 mg/ml. trenbolone hexahydrobenzyl carbonate:50 mg/ml, trenbolone enanthate 50 mg/ml
Pack: 10 ml vial (150mg/ml)
Carrier oil: Sesame oil
Overview:
Trenbolone Enanthate represents one of the most powerful injectable anabolic steroids available, designed exclusively for experienced performance athletes. As a modified 19-nortestosterone compound, its unique molecular structure delivers unparalleled anabolic potency while resisting metabolic breakdown.
Key Characteristics:
Exceptional Potency: With an anabolic/androgenic rating of 500:500 (vs testosterone’s 100:100), 200mg delivers comparable effects to 1000mg testosterone
Non-aromatizing: Completely resistant to estrogen conversion, eliminating water retention
IGF-1 Stimulation: Enhances local muscle growth factors beyond typical AAS effects
Veterinary Origin: Currently approved for livestock growth promotion, with emerging medical research potential
Performance Benefits:
✓ Rapid Lean Mass Development – Significant nitrogen retention promotes quality tissue growth
✓ Enhanced Metabolic Activity – Androgen receptor activation in adipocytes accelerates lipolysis
✓ Anti-Catabolic Protection – Cortisol receptor binding preserves muscle during caloric deficit
✓ Strength Optimization – Neuromuscular efficiency improvements support progressive overload
Clinical Profile:
Administration: 200mg/mL concentration in sterile oil solution (intramuscular)
Dosing Protocol: 200-600mg weekly (divided doses)
Half-Life: Approximately 7-10 days (enanthate ester)
Detection Time: Up to 5 months post-administration
Safety Considerations:
Contraindications:
Prostate/breast malignancies
Severe cardiovascular conditions
Uncontrolled hypertension
Pregnancy/lactation
Potential Adverse Effects:
• Endogenous testosterone suppression
• Sleep architecture disruption
• Prolactin elevation (dose-dependent)
• Androgenic dermatological manifestations
Optimal Usage:
Cycle Planning: Minimum 8-week duration recommended
Supportive Agents: Dopamine agonists recommended at >400mg/week
Post-Cycle Therapy: Required for HPTA restoration
Pharmaceutical Specifications:
Storage: 15-25°C protected from light
Stability: 24 months unopened
Presentation: 10mL multi-dose vial
Important Notice:
This compound is classified as a Schedule III controlled substance in most jurisdictions. The information provided is for educational purposes only regarding the pharmacological properties of trenbolone enanthate. Always consult with licensed medical professionals before considering any performance-enhancing regimen.
Laboratory Notes:
Recent HPLC analysis confirms:
98.7% purity (Batch #TRN-2024-EU)
<0.5% residual solvents Sterility tested (USP <71> compliant)